1-7 of 7
Peter Stewart
Close
Sort by
Journal Articles

Interim Analyses from the Beacon Trial: A Phase 2, Randomized, Open-Label Trial of Bitopertin in Erythropoietic Protoporphyria

Gayle Ross, Peter Stewart, George Mensing, Melanie Chin, Haley Howell, Heidi Mangus, William Savage
Journal: Blood
Blood (2023) 142 (Supplement 1): 923.
https://doi.org/10.1182/blood-2023-175011
Published: 2023
Journal Articles

Karyosequencing: Integrating Genome-Wide and Targeted Sequencing for Comprehensive Diagnosis of Lymphoproliferative Disorders

James Peter Stewart, Louise Harewood, Shambhavi Srivastava, Jana Gazdova, Manisha Maurya, Sirintra Nakjang, Elizabeth Hodges, Laura Chiecchio, Nicholas C.P. Cross, Matthew W Jenner, Mark Catherwood, Sarra Ryan, Anthony V. Moorman, Nikos Darzentas, David Gonzalez
Journal: Blood
Blood (2021) 138 (Supplement 1): 272.
https://doi.org/10.1182/blood-2021-152258
Published: 2021
Journal Articles

Euroclonality-NGS DNA Capture Panel for Integrated Analysis of IG/TR Rearrangements, Translocations, Copy Number and Sequence Variation in Lymphoproliferative Disorders

Peter Stewart, PhD, Jana Gazdova, MSc, Nikos Darzentas, PhD, Dorte Wren, PhDFRCPath, Paula Proszek, Grazia Fazio, Simona Songia, Miguel Alcoceba, Maria Eugenia Sarasquete, PhD, Patrick Villarese, PhD, Michèle Y van der Klift, Kim Heezen, Neil McCafferty, MSc, Karol Pal, MSc, Mark Catherwood, PhD, Chang Sik Kim, PhD, Shambhavi Srivastava, PhD, Elizabeth Hodges, PhD, Kostas Stamatopoulos, Wolfram Klapper, Simone Ferrero, MD, Michiel van den Brand, MD, Giovanni Cazzaniga, PhD, Frederic Davi, MD PhD, Ramon Garcia-Sanz, MD PhD, Patricia Groenen, Elizabeth Macintyre, PhDMD, Monika Brüggemann, Christiane Pott, MD PhD, Elisa Genuardi, Anton W Langerak, PhD, David Gonzalez, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 888.
https://doi.org/10.1182/blood-2019-127822
Published: 2019
Journal Articles

Loss of CYR61 in Myeloma Microenvironment Is Associated with Poor Survival

Sarah K. Johnson, PhD, Peter Stewart, PhD, Shmuel Yaccoby, PhD, Fenghuang Zhan, MD, PhD, Bart Barlogie, MD, Ph.D, John D Shaughnessy, Jr., PhD
Journal: Blood
Blood (2011) 118 (21): 1813.
https://doi.org/10.1182/blood.V118.21.1813.1813
Published: 2011
Journal Articles

Abnormally High Levels of E- and N-Cadherin Expression Add to Altered Regulation of b-Catenin In Multiple Myeloma

Ya-Wei Qiang, MD, PhD, Peter Stewart, PhD, Yu Chen, Bo Hu, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2982.
https://doi.org/10.1182/blood.V116.21.2982.2982
Published: 2010
Journal Articles

Shorter Post-Relapse Survival (PRS) of Myeloma (MM) Patients Randomized to the Thalidomide (T) Arm of Total Therapy 2 (TT2) Related to Chromosome 1q21 Amplification (AMP1Q21, FISH) at Relapse.

Bart Barlogie, Ichiro Hanamura, Bart Burington, Erik Rasmussen, Peter Stewart, Guido Tricot, Elias Anaissie, Maurizio Zangari, Frits van Rhee, Klaus Hollmig, Teresa Milner, Joshua Epstein, John Crowley, John Shaughnessy
Journal: Blood
Blood (2005) 106 (11): 1155.
https://doi.org/10.1182/blood.V106.11.1155.1155
Published: 2005
Journal Articles

Frequent Gains of Chromosome Arm 1q21 in Plasma Cell Dyscrasia Detected by Fluorescence In Situ Hybridization: Incidence Increases from MGUS to Relapsed Myeloma and Is Related to Disease Progression and Prognosis.

Ichiro Hanamura, MD, Peter Stewart, PhD, Frederica Cavallo, MD, Bart Burington, MS, Erik Rasmussen, MS, John Crowley, PhD, Fenghuang Zhan, MD, PhD, Yongsheng Huang, MS, Bart Barlogie, MD, PhD, John Shaughnessy, PhD
Journal: Blood
Blood (2005) 106 (11): 1553.
https://doi.org/10.1182/blood.V106.11.1553.1553
Published: 2005